Recently, Rincon-Arevalo et al., by studying the expression of phosphorylated and unphosphorylated STAT1 in patients with mild or severe COVID-19, suggested a model to understand when to prefer a treatment with interferons or with drugs capable of blocking interferon signaling [133]. The gene discussed is STAT1; the disease is COVID-19.